Driving the Deal | Insights from JPM 2024

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Farragut’s own Assistant Vice President, Holly Stokes. Holly provides an update and 2024 outlook for the No Surprises Act (NSA). They discuss the carve out, as well as the status of the committee and their recommendations. Along with this update, they share their thoughts on the NSA’s potential impact on the industry.

The Driving the Deal podcast is back for its fourth season! We're bringing you the latest topics impacting the healthcare private equity space. In this new episode, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, McDermott Partner and co-head of the Firm’s Private Equity Practice Group, are joined by Farragut Square Group’s Assistant Vice President, Holly Stokes, and Director of Research, Jackie Williams, to provide insights from the 2024 J.P. Morgan Healthcare Conference in San Francisco. Together, they discuss what people are expecting this year in the deal market, providing key takeaways and sharing their thoughts on various sector themes.

 In this special episode of a multi-part series, host Brian Fortune, senior managing director at Farragut Square Group, is joined by his colleague, Devin Stone, head of data analytics at McDermott+ Consulting (M+) and former economist at Centers for Medicare and Medicaid Services Office of the Actuary, where he served as co-lead for the 2016-2025 national health expenditure projections. They embark on the first ever videocast edition of Driving the Deal, which can be found on Farragut’s YouTube page (link below). Together, they highlight interesting trends and offer their own thoughts on CMS’s national health expenditures projections for 2022 through 2031, current healthcare spending, national health insurance coverage, and Medicare Fee-for-Service & Medicare Advantage enrollment.

Youtube Link: https://youtu.be/c0QTaaOf9c4?si=39XQDR3XPZ_m843e

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, and Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, sit down with John Jamison, Director of Healthcare Investment Banking at Cantor Fitzgerald. Together, they discuss the macroenvironment of the allergy and ENT space, commenting on what’s sparking interest in the sector and what’s in store for the next year. Additionally, they take a look at the service mix and provide thoughts on investing in the space.

We’re delighted to offer the latest episode in our popular series of podcast dialogues with Ken Kaufman, co-founder and managing director of healthcare management consulting firm Kaufman Hall.

In this episode, Ken and host Michael Peregrine return to the social science concept of “wicked problems”—problems that have no single, correct solution. In fact, a solution that improves one aspect of a wicked problem usually makes another aspect of the problem worse.

Ken believes that the current hospital operating environment is overwhelmed by wicked problems. During the conversation, he shares his insight on:

• How wicked problems impact hospital-client issues
• Keeping management and boards appropriately informed and engaged, including key metrics that board members must be aware of
• Balancing the crisis of regulation with a hospital’s need to scale
• Addressing and debriefing the board on post-COVID-19 strategies
• Managing media and political attacks on hospitals

Additional Resources:

McDermott Will & Emery

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by his colleague, Sharon Lamb, Partner and head of the U.K. health practice at McDermott Will & Emery. Together, they debrief HPE Europe 2023, discussing their findings on investment trends and opportunities, as well as current market challenges. They also provide insight on innovative advancements, market dynamics, and forecasts for 2024.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Houlihan Lokey’s own Mark Francis, Managing Director and Global Head of its Healthcare Group. Together, they discuss the sectors expected to see an increase in deal volume and activity, a review of activity and deal flow in the last three quarters, sectors that are cooling off, the impact of digital health in the healthcare industry, and an outlook for the rest of the year and 2024.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by FSG’s own Assistant Vice President, Holly Stokes, in an insightful overview of the recently released 2024 Physician Fee Schedule (PFS) proposed rule. They shed light on the PFS’s significance and impact on providers. Holly provides a comprehensive overview of the proposed changes, including the notable 3.4% cut to the conversion factor, and presents an outlook for potential congressional intervention as well as other specialty-specific changes.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by L.A. Galyon IV, managing partner at Brentwood Capital Advisors, for the final segment of our three-part behavioral health series. Together, they have a riveting conversation on the psychiatry space, discussing today’s macro-environment and service mix. Additionally, they provide insights on current reimbursement issues and investment opportunities within the sector.

During this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by L.A. Galyon IV, managing partner at Brentwood Capital Advisors, for part two in our three-part behavioral health series. Together, they delve into the substance use disorder (SUD) space and its macro environment. They also share their thoughts on the evolving demand for relevant services in recent years and provide valuable insights on investment opportunities within the SUD sector.